Paul Szabolcs
Clinical trials sponsored by Paul Szabolcs, explained in plain language.
-
Could a stem cell transplant tame severe Crohn's?
Disease control Recruiting nowThis study tests if high-dose chemotherapy followed by a stem cell transplant can help control severe Crohn's disease in children and adults aged 10 to 60. The treatment aims to reset the immune system and reduce inflammation. Researchers will monitor side effects and how long sy…
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy and radiation regimen before a stem cell transplant for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler prepar…
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Double transplant trial offers new hope for lung and blood failure patients
Disease control Recruiting nowThis study tests if a lung transplant followed by a bone marrow transplant can help people with both severe lung disease (like pulmonary fibrosis or COPD) and bone marrow failure. Up to 8 adults aged 18-60 will receive a lung transplant first to improve breathing, then a bone mar…
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Stem cell transplant offers new hope for rare immune diseases
Disease control Recruiting nowThis study tests a stem cell transplant for people with common variable immunodeficiency (CVID) and other immune disorders. The goal is to replace the faulty immune system with a healthy donor's stem cells. Participants are aged 5 to 40 and will receive a reduced-intensity transp…
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Experimental stem cell therapy offers hope for young scleroderma patients
Disease control Recruiting nowThis study tests a stem cell transplant for people aged 8-24 with severe systemic sclerosis (scleroderma) that hasn't improved with standard treatments. The approach uses high-dose therapy to reset the immune system, followed by a transplant of the patient's own blood stem cells.…
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
New transplant approach aims to control severe immune and blood disorders
Disease control Recruiting nowThis study tracks children and adults with non-cancerous blood or immune disorders who receive a stem cell transplant using a milder chemotherapy regimen. The goal is to see how well the transplant works and to monitor side effects like graft-versus-host disease. Up to 50 partici…
Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 22, 2026 14:02 UTC